Lymphoid Reaction Observed in Eczema Patients Receiving Dupilumab

MONDAY, Oct. 30, 2023-- For adults with atopic dermatitis (AD) receiving dupilumab treatment, a reversible lymphoid reaction (LR) has been observed, which mimics cutaneous T-cell lymphoma (CTCL), according to a study published online Oct. 18 in...